机译:糖尿病血液透析患者的血糖控制和心血管死亡率
Harold Simmons Center for Chronic Disease Research and Epide- miology, Los Angeles Biomedical Research Institute at Harbor-UCLA Med- ical Center, Torrance, California;
Harold Simmons Center for Chronic Disease Research and Epide- miology, Los Angeles Biomedical Research Institute at Harbor-UCLA Med- ical Center, Torrance, California,Institute of Pathophysiology, Semmelweis University, Budapest, Hungary;
Division of Nephrology, Salem VA Medical Center, Salem, Virginia,Division of Nephrology, University of Virginia, Charlottesville, Virginia;
Division of Nephrology and Hypertension, Harbor-UCLA Medical Center, Torrance, California;
DaVita Inc., Denver, Colorado,David Geffen School of Medicine at UCLA, Los Angeles, California;
Harold Simmons Center for Chronic Disease Research and Epide- miology, Los Angeles Biomedical Research Institute at Harbor-UCLA Med- ical Center, Torrance, California;
Harold Simmons Center for Chronic Disease Research and Epide- miology, Los Angeles Biomedical Research Institute at Harbor-UCLA Med- ical Center, Torrance, California,Division of Nephrology and Hypertension, Harbor-UCLA Medical Center, Torrance, California,David Geffen School of Medicine at UCLA, Los Angeles, California,Department of Epidemiology, UCLA School of Public Health, Los Angeles, California;
机译:糖尿病患者糖尿病患者心血管患者心血管成果的关联
机译:血糖控制不良是糖尿病慢性血液透析患者心血管事件的重要预测指标。
机译:血糖控制改变了韩国全国范围内前瞻性队列糖尿病患者的血液透析和腹膜透析死亡率风险的差异
机译:血液透析糖尿病患者血糖控制的靶向和治疗方法
机译:患有心血管疾病的2型糖尿病患者的健康结局:护理人员和血糖控制的评估。
机译:糖尿病血液透析患者的血糖控制和心血管死亡率
机译:强化收缩血压降低对2型糖尿病患者心血管事件和死亡率的影响标准血糖对照和糖尿病患者的影响:协调BP和Sprint协调结果